MedKoo Cat#: 128456 | Name: ​360A (iodide)
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

360A is an inhibitor of telomerase (IC50 = 0.3 µM). It decreases the viability of in T98G glioma fibroblasts, CB193 astrocytoma and U-118 MG glioma cells, and primary human astrocytes (IC50s = 4.8, 3.9, 8.4, and 17.4 µM, respectively).

Chemical Structure

​360A (iodide)
​360A (iodide)
CAS#737763-37-0

Theoretical Analysis

MedKoo Cat#: 128456

Name: ​360A (iodide)

CAS#: 737763-37-0

Chemical Formula: C27H23I2N5O2

Exact Mass: 0.0000

Molecular Weight: 703.32

Elemental Analysis: C, 46.11; H, 3.30; I, 36.09; N, 9.96; O, 4.55

Price and Availability

Size Price Availability Quantity
5mg USD 450.00 2 Weeks
10mg USD 850.00 2 Weeks
25mg USD 1,350.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
​360A (iodide); ​360A iodide; ​360A
IUPAC/Chemical Name
3,3'-((pyridine-2,6-dicarbonyl)bis(azanediyl))bis(1-methylquinolin-1-ium) iodide
InChi Key
CYDYPTJPHHNFEL-UHFFFAOYSA-N
InChi Code
InChI=1S/C27H21N5O2.2HI/c1-31-16-20(14-18-8-3-5-12-24(18)31)28-26(33)22-10-7-11-23(30-22)27(34)29-21-15-19-9-4-6-13-25(19)32(2)17-21;;/h3-17H,1-2H3;2*1H
SMILES Code
O=C(C1=CC=CC(C(NC2=CC3=C([N+](C)=C2)C=CC=C3)=O)=N1)NC4=CC5=C([N+](C)=C4)C=CC=C5.[I-].[I-]
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 703.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Hwang IP, Mailliet P, Hossard V, Riou JF, Bugaut A, Roger L. Investigating the Effect of Mono- and Dimeric 360A G-Quadruplex Ligands on Telomere Stability by Single Telomere Length Analysis (STELA). Molecules. 2019 Feb 6;24(3):577. doi: 10.3390/molecules24030577. PMID: 30736276; PMCID: PMC6384687. 2: Pennarun G, Granotier C, Hoffschir F, Mandine E, Biard D, Gauthier LR, Boussin FD. Role of ATM in the telomere response to the G-quadruplex ligand 360A. Nucleic Acids Res. 2008 Mar;36(5):1741-54. doi: 10.1093/nar/gkn026. Epub 2008 Feb 7. PMID: 18263609; PMCID: PMC2275132. 3: Stoor K, Karvonen E, Liinamaa J, Saarela V. Evaluating refraction and visual acuity with the Nidek autorefractometer AR-360A in a randomized population-based screening study. Acta Ophthalmol. 2018 Jun;96(4):384-389. doi: 10.1111/aos.13636. Epub 2017 Nov 30. PMID: 29193822. 4: Gauthier LR, Granotier C, Hoffschir F, Etienne O, Ayouaz A, Desmaze C, Mailliet P, Biard DS, Boussin FD. Rad51 and DNA-PKcs are involved in the generation of specific telomere aberrations induced by the quadruplex ligand 360A that impair mitotic cell progression and lead to cell death. Cell Mol Life Sci. 2012 Feb;69(4):629-40. doi: 10.1007/s00018-011-0767-6. Epub 2011 Jul 20. PMID: 21773671; PMCID: PMC3265728. 5: Ghoraba HH, Ellakwa AF, Ghali AA, Abdel Fattah HM. Long-term results of 360A° scleral buckling and vitrectomy with silicone oil tamponade for management of gunshot-perforating ocular injury. Eye (Lond). 2012 Oct;26(10):1318-23. doi: 10.1038/eye.2012.150. Epub 2012 Aug 3. PMID: 22863820; PMCID: PMC3470064.